N-[4-bromo-2-(2-pyridylcarbonyl)phenyl]-2-chloroacetamide (CAS 41526-21-0) — formula C14H10BrClN2O2, molecular weight 353.60; category organic chemicals.
| CAS Number | 41526-21-0 |
|---|---|
| Molecular Formula | C14H10BrClN2O2 |
| Molecular Weight | 353.60 |
| LogP | 3.6 |
| Category | Organic Chemicals |
N-[4-bromo-2-(2-pyridylcarbonyl)phenyl]-2-chloroacetamide is a carbon-based organic compound with CAS registry number 41526-21-0 and molecular formula C14H10BrClN2O2 (molecular weight 353.60), belonging to the organic chemicals segment of chemical raw materials.
CAS number: 41526-21-0
Its molecular formula C14H10BrClN2O2 comprises 14 C, 10 H, 1 Br, 1 Cl, 2 N, 2 O atoms.
Also known as: N-[4-bromo-2-(2-pyridylcarbonyl)phenyl]-2-chloroacetamide · N-[4-溴-2-(2-吡啶基羰基)苯基]-2-氯乙酰胺
Category: organic chemicals
The CAS registry number of N-[4-bromo-2-(2-pyridylcarbonyl)phenyl]-2-chloroacetamide is 41526-21-0.
Molecular formula C14H10BrClN2O2, molecular weight 353.60.
It is also registered under: N-[4-bromo-2-(2-pyridylcarbonyl)phenyl]-2-chloroacetamide, N-[4-溴-2-(2-吡啶基羰基)苯基]-2-氯乙酰胺.
Category: Organic Chemicals.
Independent reference data for N-[4-bromo-2-(2-pyridylcarbonyl)phenyl]-2-chloroacetamide (CAS 41526-21-0), compiled from public chemistry databases.
| CAS Registry Number | 41526-21-0 |
|---|---|
| PubChem CID | 3016284 |
| Molecular formula | C14H10BrClN2O2 |
| IUPAC name | N-[4-bromo-2-(pyridine-2-carbonyl)phenyl]-2-chloroacetamide |
| UNII (FDA) | W2E7F48BSD |
| Molecular Weight | 353.60 |
|---|---|
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 351.96142 |
| Monoisotopic Mass | 351.96142 |
| Topological Polar Surface Area | 59.1 |
| Heavy Atom Count | 20 |
41526-21-0; N-[4-BROMO-2-(2-PYRIDYLCARBONYL)PHENYL]-2-CHLOROACETAMIDE; EINECS 255-427-7; N-(4-Bromo-2-(2-pyridylcarbonyl)phenyl)-2-chloroacetamide; DTXSID70194400; RefChem:827178; DTXCID40116891; 255-427-7; N-(4-Bromo-2-picolinoylphenyl)-2-chloroacetamide; Bromazepam EP Impurity B; N-[4-bromo-2-(pyridine-2-carbonyl)phenyl]-2-chloroacetamide; C14H10BrClN2O2; 2-(2-Chloroacetamido-5-bromobenzoyl)pyridine; MFCD09743853; N-[4-Bromo-2-(pyridin-2-ylcarbonyl)phenyl]-2-chloroacetamide; N-[4-Bromo-2-(pyridin-2-ylcarbonyl)phenyl]-2-chloroacetamide; Bromazepam Imp. B (EP); Bromazepam Impurity B
| GHS notification summary | 50% (2 / 4) |
|---|
| GHS notification summary | 50% (2 / 4) |
|---|---|
| Reported hazard statements | H302 (50%), H315 (25%), H319 (25%), H335 (25%) |
This chemical does not meet GHS hazard criteria for 50% (2 of 4) of reports.
H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]
N-[4-bromo-2-(2-pyridylcarbonyl)phenyl]-2-chloroacetamide · CAS 41526-21-0 · C14H10BrClN2O2. UNII W2E7F48BSD.
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd.